Aethlon had a cash balance of approximately $4.8M. “During the third fiscal quarter and subsequent period, we continued to advance our oncology trials, including treatment of the first patient at ...

The Company's fourth fiscal quarter 2024 net earnings attributable to VPG stockholders were $0.8 million, or $0.06 per diluted share, compared to $4.2 million, or $0.31 per diluted share, in the ...